RT @RichardPAConway: Tillett et al. Baseline characteristics and achievement of MDA at week 24 with IL23i guselkumab in
Tweet Content
Tillett et al. Baseline characteristics and achievement of MDA at week 24 with IL23i guselkumab in bDMARD experienced patients. Pattern of joint (wrist vs shoulder/hand) and skin (scalp vs hand/foot) involvement, as well as male sex, predictive @RheumNow #EULAR2022 POS1051 https://t.co/lHOTgMWgMA
Show on Archive Page
On
Display in Search Results
On
PDQ
Off